ArticleCancers2024

Combined Cytokine Blockade Therapy (CCBT) Using Basiliximab and Infliximab for Treatment of Steroid-Refractory Graft-Versus-Host Disease (SR-GvHD).

Hoda Pourhassan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.